Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tetrabenazine

Next Previous
X
Search
Drug Profile

Tetrabenazine

Alternative Names: BVF-018; Choreazine Tablets 12.5mg; Nitoman; Xenazina; Xenazine; Xenazine 25

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LifeHealth Limited
  • Developer AFT Pharmaceuticals; Alfresa Pharma Corporation; ApotheekZorg; Cambridge Laboratories; Chiesi Farmaceutici; EUSA Pharma; Lundbeck A/S; Medilink Pharmaceuticals; Orphan Australia; Temmler Pharma; UCB; Valeant Canada
  • Class Antipsychotics; Quinolizines; Small molecules
  • Mechanism of Action Dopamine receptor antagonists; Vesicular monoamine transporter 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Huntington's disease; Gilles de la Tourette's syndrome
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Huntington's disease; Movement disorders; Tardive dyskinesia
  • Discontinued Gilles de la Tourette's syndrome

Most Recent Events

  • 12 Jun 2012 EUSA Pharma has been acquired by Jazz Pharmaceuticals plc
  • 28 Sep 2010 Biovail Corporation merged with Valeant Pharmaceuticals International forming Valeant Pharmaceuticals International
  • 19 May 2009 Biovail Corporation enters into an agreement to acquire tetrabenazine from Cambridge Laboratories

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top